In this issue of the BJGP, Koshiaris and colleagues present a primary care electronic health records study that examines the combined predictive value for multiple myeloma of presenting symptoms and blood tests commonly used in primary care.1 Building on previous related research,2 this study reports important new evidence that could help doctors to both shorten diagnostic intervals in patients with this (very hard-to-suspect) cancer and minimise the need for specialist assessment in those unlikely to have the disease. A key finding is that in patients with persistent back or bone pain the combination of normal full-blood count and normal erythrocyte sedimentation rate/plasma viscosity can help to reasonably rule out the risk of multiple my...
More than 144 000 Australians were diagnosed with cancer in 2019. Diagnosing cancer in primary care ...
This is the final version of the article. Available from Cancer Research UK/Nature Publishing Group ...
PURPOSE: Monoclonal gammopathy of undetermined significance (MGUS) is a prevalent yet largely asympt...
This is the author accepted manuscript. The final version is available from Royal College of General...
BACKGROUND: Multiple myeloma is a haematological cancer characterised by numerous non-specific sympt...
Background: Multiple myeloma is a haematological cancer characterised by numerous non-specific sympt...
Background Multiple myeloma is a type of blood cancer which starts at the bone marrow. Fifty percent...
Multiple myeloma (MM) is a hematological malignancy arising from differentiated B-lymphocyte white b...
Myeloma is one of the hardest cancers to diagnose in primary care due to its rarity and non-specific...
Background Patients with myeloma experience substantial delays in their diagnosis, which can adverse...
Background Unexpected weight loss (UWL) is a presenting feature of cancer in primary care. Existing ...
Abstract Background Simple blood tests can play an important role in identifying patients for cancer...
The diagnosis of multiple myeloma (MM) can be challenging, especially in patients with light-chain o...
Background/Aims: Multiple myeloma is a rare plasma cell cancer that disproportionately affects men a...
Cancer Research UKNational Institute for Health Research (NIHR)Policy Research Unit in Cancer Awaren...
More than 144 000 Australians were diagnosed with cancer in 2019. Diagnosing cancer in primary care ...
This is the final version of the article. Available from Cancer Research UK/Nature Publishing Group ...
PURPOSE: Monoclonal gammopathy of undetermined significance (MGUS) is a prevalent yet largely asympt...
This is the author accepted manuscript. The final version is available from Royal College of General...
BACKGROUND: Multiple myeloma is a haematological cancer characterised by numerous non-specific sympt...
Background: Multiple myeloma is a haematological cancer characterised by numerous non-specific sympt...
Background Multiple myeloma is a type of blood cancer which starts at the bone marrow. Fifty percent...
Multiple myeloma (MM) is a hematological malignancy arising from differentiated B-lymphocyte white b...
Myeloma is one of the hardest cancers to diagnose in primary care due to its rarity and non-specific...
Background Patients with myeloma experience substantial delays in their diagnosis, which can adverse...
Background Unexpected weight loss (UWL) is a presenting feature of cancer in primary care. Existing ...
Abstract Background Simple blood tests can play an important role in identifying patients for cancer...
The diagnosis of multiple myeloma (MM) can be challenging, especially in patients with light-chain o...
Background/Aims: Multiple myeloma is a rare plasma cell cancer that disproportionately affects men a...
Cancer Research UKNational Institute for Health Research (NIHR)Policy Research Unit in Cancer Awaren...
More than 144 000 Australians were diagnosed with cancer in 2019. Diagnosing cancer in primary care ...
This is the final version of the article. Available from Cancer Research UK/Nature Publishing Group ...
PURPOSE: Monoclonal gammopathy of undetermined significance (MGUS) is a prevalent yet largely asympt...